PL4188332T3 - Urządzenie do leczenia anafilaksji - Google Patents

Urządzenie do leczenia anafilaksji

Info

Publication number
PL4188332T3
PL4188332T3 PL22716648.5T PL22716648T PL4188332T3 PL 4188332 T3 PL4188332 T3 PL 4188332T3 PL 22716648 T PL22716648 T PL 22716648T PL 4188332 T3 PL4188332 T3 PL 4188332T3
Authority
PL
Poland
Prior art keywords
treating anaphylaxis
anaphylaxis
treating
Prior art date
Application number
PL22716648.5T
Other languages
English (en)
Polish (pl)
Inventor
George Harry LUCIUK
Andrew Robert MARTIN
Conor Aidan RUZYCKI
Warren Hugh Finlay
Original Assignee
Kokua Pharma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kokua Pharma Inc. filed Critical Kokua Pharma Inc.
Publication of PL4188332T3 publication Critical patent/PL4188332T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A61M11/003—Particle size control by passing the aerosol trough sieves or filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C19/00—Acyclic saturated compounds containing halogen atoms
    • C07C19/08—Acyclic saturated compounds containing halogen atoms containing fluorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00—Ancillary equipment
    • A61M2209/02—Equipment for testing the apparatus

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processing Of Meat And Fish (AREA)
  • Surgical Instruments (AREA)
  • Non-Portable Lighting Devices Or Systems Thereof (AREA)
PL22716648.5T 2021-03-23 2022-03-23 Urządzenie do leczenia anafilaksji PL4188332T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163165102P 2021-03-23 2021-03-23
PCT/US2022/021612 WO2022204328A1 (en) 2021-03-23 2022-03-23 Device for treating anaphylaxis

Publications (1)

Publication Number Publication Date
PL4188332T3 true PL4188332T3 (pl) 2025-11-24

Family

ID=81307871

Family Applications (1)

Application Number Title Priority Date Filing Date
PL22716648.5T PL4188332T3 (pl) 2021-03-23 2022-03-23 Urządzenie do leczenia anafilaksji

Country Status (20)

Country Link
US (1) US20220331237A1 (cg-RX-API-DMAC7.html)
EP (2) EP4188332B1 (cg-RX-API-DMAC7.html)
JP (2) JP2024515446A (cg-RX-API-DMAC7.html)
KR (1) KR20230165764A (cg-RX-API-DMAC7.html)
CN (1) CN117083054A (cg-RX-API-DMAC7.html)
AU (1) AU2022245300B2 (cg-RX-API-DMAC7.html)
BR (1) BR112023019156A2 (cg-RX-API-DMAC7.html)
CA (1) CA3212189A1 (cg-RX-API-DMAC7.html)
DK (1) DK4188332T3 (cg-RX-API-DMAC7.html)
ES (2) ES3025005T3 (cg-RX-API-DMAC7.html)
FI (1) FI4188332T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20250566T1 (cg-RX-API-DMAC7.html)
HU (1) HUE071185T2 (cg-RX-API-DMAC7.html)
IL (1) IL305534A (cg-RX-API-DMAC7.html)
LT (1) LT4188332T (cg-RX-API-DMAC7.html)
PL (1) PL4188332T3 (cg-RX-API-DMAC7.html)
PT (1) PT4188332T (cg-RX-API-DMAC7.html)
RS (1) RS66787B1 (cg-RX-API-DMAC7.html)
SI (1) SI4188332T1 (cg-RX-API-DMAC7.html)
WO (1) WO2022204328A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12514995B2 (en) * 2021-02-15 2026-01-06 Glenmark Pharmaceuticals Limited Metered dose inhalers of fluticasone or an ester thereof
WO2025072756A1 (en) * 2023-09-28 2025-04-03 Kokua Pharma Inc. Device, methods, and uses for treating acute allergic reactions
WO2025170986A1 (en) * 2024-02-06 2025-08-14 Kindeva Drug Delivery L.P. Drug delivery device
US20260007598A1 (en) * 2024-07-05 2026-01-08 Honeywell International Inc. Compositions, devices and methods for respritory delivery of active pharmaceutical ingredients
US12496272B1 (en) * 2024-07-31 2025-12-16 Amphastar Pharmaceuticals, Inc. Stable epinephrine suspension formulation for inhalation with HFO propellant

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9324250D0 (en) * 1993-11-25 1994-01-12 Minnesota Mining & Mfg Inhaler
EP1321159A1 (en) 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
EP1531794B1 (en) * 2002-06-28 2017-05-10 Civitas Therapeutics, Inc. Inhalable epinephrine
AU2004249166B2 (en) * 2003-06-13 2008-10-09 Alkermes, Inc. Low dose pharmaceutical powders for inhalation
WO2006101882A2 (en) * 2005-03-16 2006-09-28 Honeywell International Inc. Medicament delivery formulations, devices and methods
US8367734B1 (en) * 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
US8268347B1 (en) * 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
GB0801876D0 (en) * 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
SI2627386T1 (sl) * 2010-10-12 2015-10-30 Ivax Pharmaceuticals Ireland Nosna pršilna naprava
US20120204871A1 (en) * 2011-02-10 2012-08-16 Julio Cesar Vega Stable, non-corrosive formulations for pressurized metered dose inhalers
WO2014033057A1 (en) * 2012-08-29 2014-03-06 Chiesi Farmaceutici S.P.A. Aerosol inhalation device
US10039710B2 (en) * 2015-09-18 2018-08-07 Insys Development Company, Inc. Epinephrine spray formulations
US9717683B1 (en) * 2016-06-29 2017-08-01 Ep Pharma, Llc Low-temperature inhalation administration of cannabinoid entities
ES2791775B2 (es) * 2018-02-06 2023-01-20 Aegis Therapeutics Llc Formulaciones de epinefrina intranasal y metodos para el tratamiento de enfermedades
WO2019182745A1 (en) * 2018-03-19 2019-09-26 Bryn Pharma, LLC Epinephrine spray formulations

Also Published As

Publication number Publication date
KR20230165764A (ko) 2023-12-05
JP2024515446A (ja) 2024-04-10
EP4188332A1 (en) 2023-06-07
CN117083054A (zh) 2023-11-17
EP4188332B1 (en) 2025-02-12
ES3025005T3 (en) 2025-06-05
RS66787B1 (sr) 2025-06-30
EP4545122C0 (en) 2026-07-15
AU2022245300A1 (en) 2023-09-14
IL305534A (en) 2023-10-01
CA3212189A1 (en) 2022-09-29
LT4188332T (lt) 2025-05-12
EP4545122A2 (en) 2025-04-30
WO2022204328A1 (en) 2022-09-29
SI4188332T1 (sl) 2025-07-31
FI4188332T3 (fi) 2025-05-06
HUE071185T2 (hu) 2025-08-28
JP2026094267A (ja) 2026-06-09
HRP20250566T1 (hr) 2025-06-20
ES3076082T3 (en) 2026-08-11
EP4545122A3 (en) 2025-05-07
DK4188332T3 (da) 2025-05-05
US20220331237A1 (en) 2022-10-20
PT4188332T (pt) 2025-04-17
BR112023019156A2 (pt) 2023-10-17
AU2022245300B2 (en) 2026-04-02
EP4545122B1 (en) 2026-07-15

Similar Documents

Publication Publication Date Title
PT4188332T (pt) Dispositivo para tratamento de anafiláxia
GB2601472B (en) Surface treatment device
ES3065436T3 (en) Device for treating vapors
CA198779S (en) Treatment device
IL312981A (en) care
GB202016058D0 (en) Therapeautic treatment
CA196805S (en) Device for treating tissue
GB202116743D0 (en) Treatment
GB202108224D0 (en) Treatment
GB202103122D0 (en) Treatment
GB202003722D0 (en) Treatment
GB202018400D0 (en) Treatment
GB202002711D0 (en) Treatment
CA207225S (en) Alopecia treatment device
PT3861863T (pt) Dispositivo de regulação de condutividade para o tratamento de células
GB202114373D0 (en) Treatment
GB202109812D0 (en) Treatment
GB202109815D0 (en) Treatment
GB202104666D0 (en) COVID-19 treatment
GB202104416D0 (en) Treatment reginmens
GB202103957D0 (en) Treatment
GB202102488D0 (en) Treatment
GB202102410D0 (en) Treatment
GB202102366D0 (en) Treatment
GB202102369D0 (en) Treatment